Overall, the human “poor prognosis” HCC signatures were significantly more prominent in the post-PHx compared to the untreated Mdr2-KO/FVB liver indicating that PHx of these mice increases the expression of the HCC development/recurrency markers in both tumor and non-tumor liver tissues even several months following the operation. This evidence concerns the gene ABCB4 and hepatocellular carcinoma.